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Abstract
Diseases don’t respect borders, so efforts to control and eliminate diseases must also be flexible and adaptable
enough to effectively reach the populations that live in the areas around national frontiers. Onchocerciasis,
commonly known as river blindness is a tropical disease that has historically affected millions of people in 35
countries in Africa and Latin America. In Africa, programs and partnerships to address river blindness through mass
drug administration have been active for more than 25 years. While in many cases the disease is found in isolated
foci that fall entirely within national boundaries, the geographic scope of many affected areas crosses country
borders. National river blindness programs are the responsibility of each nation’s Ministry of Health, so in cross-
border situations there is a need for effective country-country collaboration. Cross-border collaboration for
onchocerciasis control efforts in the countries of the Mano River Basin illustrates the positive impact of a creative
model, and offers lessons for expanded application for onchocerciasis elimination as well as other neglected
tropical disease (NTD) control and elimination programs.
Keywords: Onchocerciasis, River blindness, Neglected tropical diseases, NTDs, Africa, Health, Partnership, WHO,
Collaboration, Cross-border
Background on river blindness
Onchocerciasis, commonly known as river blindness, is
a neglected tropical disease (NTD) that is currently en-
demic in 35 countries in Africa, Latin America and the
Middle East [1]. The disease is caused by a parasite,
Onchocerca volvulus, which is transmitted by the bite of
infected black flies that breed in fast-flowing rivers. In-
fection in humans can lead to skin depigmentation and
loss of elasticity, painful nodules under the skin where
the adult parasites are lodged, and vision loss and even-
tual blindness when the parasites migrate to the eyes [2].
Initial efforts to control onchocerciasis in Africa were
through the Onchocerciasis Control Program (OCP) of
the World Health Organization (WHO), an 11 country
effort in West Africa to control the disease initially
through vector control that ran from 1975 to 2002 [3].
While vector control had positive impact on controlling
onchocerciasis, since 1987, the preferred control strategy
for onchocerciasis is annual or semi-annual treatment
with ivermectin, which kills the juvenile parasites. With
sufficient treatment coverage at the community level
over time, the cycle of transmission can eventually be
broken and the disease eliminated [1]. A second WHO
regional program in Africa, the African Program for
Onchocerciasis Control (APOC), ran from 1995 to 2015
to support the control efforts in 19 countries outside of
the OCP area (although there was some support offered
for ex-OCP countries) [4]. Onchocerciasis is one of the
10 NTDs targeted for elimination through the WHO’s
Roadmap on NTDs [5]. Achieving elimination requires* Correspondence: ken.gustavsen@merck.com1Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA
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sustained annual treatment coverage rates of >80 % at
the community level for a period of 15–20 years [1, 6].
Issues associated with cross-border coordination
Cross-border collaboration between sovereign nations
is a complex undertaking for any issue. For a disease
control and elimination program such as one for on-
chocerciasis, there is a range of issues to be consid-
ered, including mapping of endemic areas including
degrees of endemicity, and reaching contiguous af-
fected areas regardless of national borders to ensure
accurate and complete treatment coverage. Treatments are
typically coordinated according to seasonal and other con-
siderations. Cross-border synchronization of Mass Drug
Administration (MDA) can allow for more effective impact
within communities given the lifecycle of the parasite
Onchocerca volvulus and the associated vector dynamics,
and the relatively free movement of people between neigh-
boring countries. Synchronization of MDA can ensure that
the lifecycle of the parasite is broken in the shared focus in
a coordinated and widespread manner, thereby preventing
reinfection from a neighboring area where the lifecycle was
not similarly impacted. Similarly, as some countries con-
sider a move from annual to semi-annual treatment fre-
quency, cross-border alignment is necessary to ensure
complementary impact on the parasite population. As pro-
grams near the threshold for stopping treatment and deter-
mining if transmission has been halted, all adjacent,
contiguous areas must be at the same endemicity point to
prevent recrudescence [1].
Recognizing the importance of cross-border collabor-
ation for the success of the control/elimination of
onchocerciasis in Africa, the WHO’s Africa Regional
Office (WHO AFRO) Regional Committee approved in
2007 the resolution AFR/RC57/R3 calling on member
states to intensify cross-border activities to strengthen
surveillance and avoid spillage of infection to freed zones
[7]. While the resolution calls for improved cross-border
collaboration, it does not provide any guidance for how
countries are to engage in that necessary but challenging
coordination process.
Given the widespread nature of onchocerciasis across
dozens of countries in Africa, there are many cross-
border challenges and opportunities involving oncho-
cerciasis MDA. The evolution of efforts to address
onchocerciasis within the adjacent geography of three
countries within the Mano River Union: Sierra Leone,
Liberia and Guinea (Conakry), provides valuable lessons
of how cross-border collaboration can evolve to enable
effective MDA. Those lessons can be further refined to
develop a framework that can be applied more generally,
currently unexamined through this lens, providing an
opportunity for cross-border collaboration to ensure that
health gains on one side of the border are secured through
an appropriate cross-border integrated strategy.
Case Study: Sierra Leone, Liberia and Guinea
(Conakry)/Mano River Union
The Mano River Union (MRU) is an intergovernmental
body originally established between Liberia and Sierra
Leone in 1973, expanded to include Guinea (1980) and
later extended to Cote d’Ivoire (2008). Organized in
relation to the members’ shared connection to the
Mano River, the MRU “aims to strengthen the capacity
of Member States to integrate their economies and coord-
inate development programmes in the areas of peace build-
ing, as a prerequisite to any development, trade promotion,
development of industry, energy, agriculture, natural re-
sources, transport and telecommunications, monetary and
financial affairs in short, all aspects of economic and social
life of the Member States” [8].
As a result of a suggestion by MRU’s Secretary General
to the Sightsavers’ Regional Director in early 2005 to
utilize the structures of the MRU to support work on
river blindness in border areas, the mandate of the MRU
was extended in 2006 to include health. MRU member
states are active participants in the MRU river blindness
meetings, “which convene the ministries of health and
technical partners in Guinea, Cote d’Ivoire, Liberia, and
Sierra Leone to discuss and resolve cross-border NTD
issues. Coordination of NTD treatment among countries
with shared mobile populations enables each country to
support the disruption of disease transmission on a
regional level” [9].
A need had been identified to increase MDA cover-
age against river blindness in the border areas of the
MRU’s member states—in particular between Liberia
and Sierra Leone following the post–conflict environ-
ment of both countries as expressed in 2006 in a dec-
laration on Onchocerciasis Control in Africa signed by
African ministers of health in Yaoundé [10]. The direct
request was for the MRU to increase its scope from
political and economic integration to that of health in-
tegration and coordination. Sierra Leone and Guinea
were previously members of the OCP umbrella of
onchocerciasis control efforts in West Africa, providing
a foundation for this new effort to build on [3]. Following
a period of advocacy and negotiation the first meeting,
attended by Liberia, Sierra Leone and Guinea (Conakry),
was held in late 2005. By 2008 the meetings had moved
beyond information sharing and protocol and had started
to make the following recommendations:
 Onchocerciasis control teams in the three
countries should visit each other across the
borders in a bid to share knowledge and
experience.
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 Sierra Leone should conduct evaluations along the
border villages with Guinea so as to obtain the exact
picture of the onchocerciasis prevalence in those
villages.
 Members of the tripartite meeting should to come
together and mobilize resources for the
implementations of the programmes.
 Guinea shall give a technical back stop to Sierra Leone
and Liberia in the bid to achieve a higher coverage.
 Member countries should institute strong
Monitoring and Evaluation teams that will ensure
that all endemic villages are treated [11].
A meeting in 2012 went further and clearly identified
the following general challenges facing all countries,
particularly in the border areas:
 Lack of coordination of NTDs interventions
 Insufficient Community Directed Distributor (CDD)
motivation and training
 Inadequate data management
 Insufficient monitoring and evaluation at the MRU
border areas
 Inadequate logistical support
In response to the challenges raised in the 2012 meet-
ing a technical coordination committee was established
that included a representative from the NTD coordin-
ator from the ministry of health in each country [Guinea
(Conakry), Liberia, Sierra Leone and Cote d’Ivoire], a
representative from the MRU Secretariat, and one non-
governmental development organization (NGDO) part-
ner (Sightsavers). This technical committee would be the
link from the annual meeting to the field-level opera-
tions. Following the initial support by Sightsavers, follow
on participation and support has come from a number
of partners including non-governmental organizations
such as Helen Keller International and academic partners
such as the Filarial Programmes Support Unit (FPSU) at
the University of Liverpool Tropical Medicine.1
With trust established and the protocols developed for
river blindness, the terms of reference for the annual
meeting was changed to a mandate for neglected trop-
ical diseases and the collaboration on cross-border ef-
forts to control five neglected tropical diseases (NTDs):
lymphatic filariasis; schistosomiasis, trachoma, oncho-
cerciasis and soil-transmitted helminthiasis [9].
Over time, the meetings have moved from information
sharing to providing technical advice to national pro-
grammes from each of the countries represented. Al-
though member states are taking increased ownership of
their programs, much of the funding for the meetings still
comes from program partners, such as implementing
non-governmental organizations and donors. Programs
have been strengthened during this 8-year period, with the
cross border work conducted as part of the exchange of
information, ideas and technical skills, with the MRU
playing a coordination role [12].
Despite the significant progress, the process has not
been simple, with every step compounded by issues of
protocol and language. It was only in 2013, for example,
that it was a requirement for all documentation to be in
both English and French. The 2013 recommendations
show how far the collaboration has advanced since the
first meeting in 2005 [9]:
 All communications should be bilingual
 Countries should use the MRU secretariat for higher
level advocacy on cross border control with political
bodies/individuals
 Medical providers working on borders should submit
information on the border populations for planning
local border health authorities before end of 2013
 Countries should order sufficient MDA drugs for
border villages, including potential MDA-migrants;
reconcile orders quantities with MDA denominator
local border health authorities before next drug order
 Countries should ensure that the MRU and cross
border meetings are included in budgets and annual
work plans
 MRU NTD committee should conduct a midterm
review of recommendations
 Countries should recognize that MDA
synchronization is optimal, despite the challenges of
depending on donor support
 Countries should make provisions for district
officers along the border to have quarterly meetings
with cross-border neighbours
 Countries should strengthen national NTD task
forces and ensure that they meet at least annually
 Country NTD programs should expand the
information shared with MRU to include
socio-economic impact of NTDs.
The initial modest meetings and efforts at coordin-
ation between countries on NTDs helped to promote
the role of the broader MRU itself, which by 2005-6 was
a mere shadow of the dream of integration. In 2008
plans to revitalize the Union were put in place that
included a stress on health and development and a uni-
fied approach to, for example, national immunization
programmes. Following the outbreak of Ebola virus
disease (EVD) in Sierra Leone, Liberia and Guinea
(Conakry) the MRU was able to coordinate cross-border
work to help contain the disease and has played an im-
portant part in high level advocacy and reducing the
administrative processes to allow for cross border work
to be coordinated [12]. Indeed, the Ebola crisis has
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illustrated the need for enhanced community engage-
ment and education to ensure MDA is conducted in a
way that reflects the new sensitivities to public health
challenges by the general public, especially in areas
where people regularly cross national borders as part of
their daily routine. As MDA resumes in the MRU countries
for river blindness and the other neglected tropical diseases
following the outbreak of Ebola virus disease in three of the
four countries of the MRU, the need for regional collabor-
ation remains vital. For example in order to maintain good
compliance, it is important to address fear in the commu-
nity about a link between EVD and MDA as seen in Liberia
[13] and apply simple hygiene practices such as not sharing
cups of water when taking drugs during MDA. This should
be reinforced through the MRU mechanisms.
General lessons learned
An analysis of the practical steps taken in this example of
cross-border collaboration yields a general set of lessons
learned that can be applied to the range of political, ad-
ministrative, operational, technical and financial elements
of disease control programs. While each cross-border sce-
nario is unique and each element may not be relevant in
every situation, stakeholders engaged in confronting the
need for cross-border collaboration for NTDs and other
public health challenges should consider these options as
levers that can be applied to strengthen their programs
and lead to improved outcomes.
Political
 Achieve political commitment and authorization for
collaboration at the highest level possible/necessary
in each affected country
○ Link on-going disease control efforts to
higher-level political influence bodies to raise
importance on the national agendas
Administrative
 Establish a guidance document that identifies the
common objective of the collaboration and provides
an objective reference of identified key issues for all
parties to refer to in the course of the collaboration.
○ All written communications should be provided
in the official languages of each participating
country.
Operational
 Agree on a regular cycle of national disease task
force strategy meetings, at a minimum annually.
 Conduct more frequent cross-border committee
meetings between district medical officers and
associated partner organizations (e.g., NGDO)
program teams to align on tactical implementation
○ Account for these statutory meetings in each
country’s budgeting process and work plans
 Share existing training resources and co-develop
new resources to ensure sufficient and similar health
care worker training
 Align each county’s drug procurement requests to
ensure adequate and non-duplicative coverage for
border regions, also considering cross-border
migration issues
Technical
 Create a mechanism to provide complementary
technical/scientific support as necessary
 Jointly institute strong Monitoring and Evaluation
programs to ensure that all endemic villages are
treated.
 Develop joint data management and common
reporting of treatment coverage and impact on
disease.
Financial
 Advocate for and mobilize resources for the
implementation of the common elements of the
program.
Applying the lessons learned
For onchocerciasis in Africa, there are several clear
cross-border scenarios that will need to be actively ad-
dressed in order for country-level disease control and
elimination goals to be achieved. Examples include the
border areas between other West African countries,
Malawi and Mozambique, Tanzania and Uganda, and
Ethiopia and Sudan. For other NTDs, especially the
NTDs that are eligible for preventive chemotherapy
(PC-NTDs) with stated control and elimination targets,
the same considerations and principles apply. These PC
NTDs are trachoma, soil transmitted helminths, schisto-
somiasis, lymphatic filariasis and onchocerciasis. To
ensure adequate consideration is given to this important
issue, the disease-specific programs that support the PC
NTDs can evaluate their program references for inclu-
sion of specific resources to inform and support cross-
border collaboration. At the country level, neighboring
countries should consider putting in place general cross-
border collaboration frameworks based on the principles
contained herein that can be activated and customized
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as necessary. Finally, WHO could augment their existing
resolution on cross-border collaboration by providing a
framework and guidance that countries and operational
partners can implement.
Conclusions
As long as diseases are not confined to national borders,
the need will continue for effective cross-border collab-
oration to fight those diseases. The lessons learned from
the onchocerciasis program in the contiguous areas of
the countries of the Mano River Union provide a frame-
work of principles that can be applied to other cross-
border situations, not just for onchocerciasis but also for
other PC NTDs. The principles cover a range of consid-
erations: Political, administrative, operational, technical,
and financial. All partners and stakeholders involved in
these programs—WHO, national NTD programs, imple-
mentation NGDOs—should actively consider how they
can adapt and apply these principles in each unique geo-
graphic and political scenario. The importance of clearly
applying these principles will increase as the global NTD
community focuses on the targets reflected in the WHO
Roadmap on NTDs and the London Declaration. Suc-
cessful efforts to address cross-border challenges will en-
hance the collective response to control and eliminate
onchocerciasis and other NTDs, resulting in improved
health for the more than one billion people affected [5].
Endnotes
1Partners supporting NTD implementation in the 4
countries include: In Sierra Leone: United States Agency
for International Development (USAID), END in Africa,
FHI360, Helen Keller International (HKI), the Centre for
Neglected Tropical Diseases (CNTD) and Sightsavers; In
Liberia: CNTD, Sightsavers and the Organization for the
Prevention of Blindness (OPC); In Guinea: HKI, Filarial
Programmes Support Unit (FPSU), Sightsavers and
OPC; in Cote d’Ivoire: HKI, FPSU and Sightsavers.
Abbreviations
CDD, community directed distributor; MDA, mass drug administration;
NGDO, non-governmental development organization; NTD, neglected
tropical diseases; PC, preventive chemotherapy; WHO AFRO, African regional
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